Best Compounded Tirzepatide Providers (2026): How PlexusDx Compares

Last reviewed: July 23, 2026 Last updated: July 23, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you’re searching for the best compounded tirzepatide provider in 2026, the rankings you’ll see across affiliate-driven roundups generally cycle through the same five names: MEDVi, Eden, Yucca Health, Willow, and TrimRx. Each has a specific angle — MEDVi pitches all-inclusive support and a money-back policy, Eden runs flat-rate dose pricing, Yucca competes on multi-month plan pricing, Willow optimizes for same-day prescriptions, and TrimRx bundles supplement support. None of them include a genetic baseline before titration. This article walks through how those five compare, names the medication-source and clinical-oversight variables that actually matter, and shows where PlexusDx Tirzepatide Injection Protocol ($289/mo) and Tirzepatide Oral Protocol ($349/mo) sit relative to that field — because the right provider isn’t the one with the loudest ad budget. It’s the one whose pricing, oversight, and personalization match how you actually plan to use a GLP-1.

Compare the numbers: What GLP-1 programs actually cost per month →

Key takeaways

• Lowest ongoing monthly rate in this comparison: PlexusDx Tirzepatide Injection at $289/mo month-to-month is below MEDVi ($399), Yucca maintenance ($325), Willow ($399), and TrimRx’s checkout-billed $399, and near Eden’s $298 all-in. That is not a claim to be the cheapest in the category — several programs we have not verified advertise lower figures.
• Only option with a genetic baseline: none of the programs compared here includes a DNA-based test; PlexusDx offers the Precision Peptide Genetic Test ($298).
• Most delivery formats: injection ($289/mo), daily oral ($349/mo), and dual-compound GLP-Squared ($289/mo) — more formats than any of the five.
• All-inclusive, no membership: consultation, prescription, compounded medication, and shipping in one bill; Eden’s all-in rate requires a $99/mo membership.
• Compounded, not FDA-approved: every provider here dispenses compounded tirzepatide — legal under 503A/503B, not FDA-approved as a finished drug. Only Mounjaro and Zepbound are.

Compounded tirzepatide providers compared (2026)

Provider	Ongoing price (injection)	Oral option	What’s included	Genetic baseline	Medication source
PlexusDx	$289/mo MTM ($249/mo 6-mo)	Yes — $349/mo daily oral	Consult, Rx, medication, shipping; no membership	Yes — Precision Peptide Genetic Test	Licensed U.S. 503A
MEDVi	~$399/mo month-to-month	Yes — tablet, priced after intake	24/7 clinician access; money-back guarantee	No	Licensed U.S. compounding
Eden	~$298/mo all-in ($199 + $99/mo membership)	No	Flat rate across doses; money-back warranty	No	Licensed U.S. compounding
Yucca Health	$258 1st mo / $325/mo maint. (6-mo plan)	No	Lowest first-month price; multi-month commitment	No	Licensed U.S. compounding
Willow	~$399/mo	No	Same-day consult; free 2-day shipping	No	Licensed U.S. compounding
TrimRx	$349/mo advertised; $399/mo billed at checkout (Jul 2026)	No	Supplement-support bundle	No	Licensed U.S. compounding

Pricing captured April–July 2026 from each provider’s published rates or checkout; verify current pricing on each provider’s site. Full sourcing in the disclosure below.

The 2026 compounded tirzepatide landscape — who’s being compared

The provider field in this category narrowed substantially after the FDA shortage list closed for tirzepatide. The five providers cited most often in 2026 roundups — MEDVi, Eden, Yucca Health, Willow, and TrimRx — all source from licensed U.S. compounding pharmacies (503A facilities, occasionally with 503B partners) and operate as cash-pay telehealth programs. Pricing lands roughly like this: MEDVi at $399/mo ongoing for tirzepatide injections; its tirzepatide tablet is priced after its intake questionnaire, and MEDVi does not publish an ongoing tablet rate (verify on their site), Eden at about $298/mo all-in across every dose (advertised $199 plus its required $99/mo membership), Yucca Health at $325/mo on a 6-month plan (per Yucca’s published rates as of April 2026; verify on their site), Willow starting at $399/mo (per Willow’s published rates as of April 2026; verify on their site), and TrimRx, which advertises $349/mo for tirzepatide — its checkout billed $399/mo month-to-month when we completed signup in July 2026. PlexusDx is not on most affiliate roundups because we don’t pay for placement — but our month-to-month pricing is competitive across this field. Tirzepatide Injection Protocol runs $289/mo across six dose levels (2.5mg to 15mg weekly), and the Tirzepatide Oral Protocol runs $349/mo across seven daily dose levels (5mg to 25mg). Both are all-inclusive: clinical consultation, prescription, compounded medication, and shipping in one bill, with no membership fee.

How the five most-ranked providers actually compare

Strip the “best for X” affiliate copy and the providers cluster around a few real differentiators. MEDVi emphasizes 24/7 clinician access, both injectable and oral tirzepatide, and a money-back guarantee — its Trustpilot footprint is the largest of the five (14,095 reviews, 4.4/5 as of July 2026). Eden holds a flat all-in rate of about $298/mo (advertised $199 plus its required $99/mo membership) that doesn’t escalate with dose — useful for patients who expect to titrate to higher weekly doses. Yucca Health wins on absolute first-month price ($258 on a 6-month plan) but locks you into the multi-month commitment to get there. Willow optimizes for time-to-first-injection — same-day consult, free 2-day shipping — at the cost of a higher entry price. TrimRx advertises $349/mo for tirzepatide and bundles supplement support — when we completed its signup in July 2026, the checkout billed $399/mo ongoing month-to-month. None of the five programs includes a DNA-based test before dose selection. None of them offer a daily oral tirzepatide formulation at the price point PlexusDx does. And none separate the cost of compounded medication from the cost of clinical oversight — for better or worse, it’s one bundled monthly bill.

Full head-to-head: PlexusDx vs TrimRx →

Full head-to-head: PlexusDx vs MEDVi →

Where PlexusDx sits in the field

PlexusDx wasn’t built to compete on the affiliate-driven “cheapest first month” axis. We were built to be the GLP-1 protocol that incorporates a genetic baseline, offers more delivery formats than any of the five providers above, and prices below the field at the entry dose tier. The Tirzepatide Injection Protocol at $289/mo month-to-month is below MEDVi ($399), Eden ($298 all-in), Yucca ($325 maintenance), Willow ($399), and TrimRx (advertised $349/mo; checkout-billed $399/mo in July 2026) while including a clinical pathway through licensed U.S. compounding pharmacies and an optional Precision Peptide Genetic Test ($298). The Tirzepatide Oral Protocol at $349/mo (or $279/mo on the 6-month plan) is a competitively priced compounded oral tirzepatide option in the comparison — useful if you’ve had trouble with weekly injection routines, need a needle-free option, or want a daily dosing rhythm. For patients who want full GIP/GLP-1 dual-agonist mechanism with semaglutide stacking, GLP-Squared ($289/mo) is the dual-compound path none of the five providers offer.

Compounded vs FDA-approved tirzepatide — what each provider actually dispenses

This is the substantive medication question and it applies equally to all six providers in the comparison (the five from the affiliate roundup plus PlexusDx). Compounded tirzepatide is prepared by a licensed compounding pharmacy under U.S. compounding regulations — Section 503A for state-licensed pharmacies that prepare individual prescriptions, or Section 503B for FDA-registered outsourcing facilities operating under cGMP standards. Compounded tirzepatide contains the same tirzepatide active ingredient as Mounjaro and Zepbound, but the finished product has not been FDA-approved — it’s legal under the compounding statute, not under the new-drug-approval pathway. Mounjaro and Zepbound are the only FDA-approved finished tirzepatide products (FDA: Human Drug Compounding). The boxed warning for thyroid C-cell tumors applies to tirzepatide as a class based on rodent studies, regardless of whether the formulation is compounded or branded. None of the five providers in the source roundup — and PlexusDx is no different — can lawfully advertise compounded tirzepatide as “FDA-approved.” Any provider that does should be removed from your shortlist.

Why genetics matter before dose selection

Tirzepatide’s dual GIP/GLP-1 mechanism produces meaningful weight loss in clinical trials — SURMOUNT-1 reported an average 20.9% body-weight reduction over 72 weeks at the 15mg dose (Jastreboff et al., NEJM 2022). But the response distribution is wide. Variants in GIPR (the GIP receptor itself, including rs1800437), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with different response patterns to tirzepatide and semaglutide. The Precision Peptide Genetic Test maps 49 genes and 58 variants across 14 health pathways, including 34 weight-management insights, with the GIPR rs1800437 variant flagged for differential GLP-1/GIP response. None of the five programs compared here includes a DNA-based test as part of titration. PlexusDx is the only protocol in the comparison that includes a genetic baseline for pathway-level context — the test does not predict your response or select a medication; your provider makes every prescribing decision. It is available for $298.

Real annualized cost — PlexusDx vs the affiliate field

Provider rankings tend to feature the “starting at” price, not what you’ll actually pay across a year of titration. Annualized totals at ongoing rates look like this: MEDVi runs roughly $4,788/year on tirzepatide injections at $399/mo ongoing; its tablet is priced after its intake questionnaire, so a comparable annual tablet figure isn’t available from public pricing (verify on their site); Eden runs about $3,576/year all-in at $298/mo (advertised $199 plus its required $99/mo membership); Yucca Health runs roughly $3,883/year on the 6-month plan ($258 + $325 × 11, per Yucca’s published rates as of April 2026; verify on their site); Willow runs $4,788+ at $399/mo (per Willow’s published rates as of April 2026; verify on their site); TrimRx billed $399/mo month-to-month at checkout in July 2026 — roughly $4,788/year — against an advertised $349/mo. PlexusDx Tirzepatide Injection Protocol runs $3,468/year at $289/mo month-to-month (or $2,988/year at $249/mo on the 6-month plan), and the Tirzepatide Oral Protocol runs $4,188/year at $349/mo (or $3,348/year at $279/mo on the 6-month plan).On the injection path, PlexusDx carries the lowest ongoing monthly rate in this comparison — the Tirzepatide Injection Protocol annualizes to $3,468 against Eden’s $3,576 all-in, $108 less, and well below MEDVi, Yucca’s maintenance, and Willow. On the oral path, Eden’s $298/mo all-in injection rate is lower than our $349/mo oral protocol — the oral premium makes sense only if you specifically want a needle-free daily format.

How to choose the right compounded tirzepatide provider

The decision frame depends on what you’re optimizing for. If you want the lowest ongoing monthly price, PlexusDx Tirzepatide Injection at $289/mo month-to-month leads this comparison; Yucca Health’s $258 first month is the lowest single-month price, but it requires a 6-month commitment. If you need an oral tirzepatide formulation rather than an injection, PlexusDx Tirzepatide Oral Protocol ($349/mo, or $279/mo on the 6-month plan) and MEDVi’s tirzepatide tablets (ongoing tablet pricing is quoted after its intake questionnaire) are the two named programs in the comparison. If you want flat-rate pricing that doesn’t scale with dose, Eden at about $298/mo all-in (advertised $199 plus its required $99/mo membership) holds flat across doses. If you want a money-back guarantee, MEDVi posts one (per its published terms as of April 2026; verify on their site), and Eden offers a money-back warranty — lose 10% of your body weight in 6 months or get your money back. If you want a genetic baseline before titration, PlexusDx is the only provider in this comparison that includes the Precision Peptide Genetic Test as part of the protocol pathway. If you want a stacked semaglutide + tirzepatide path, GLP-Squared is the only dual-compound option named here.

Frequently Asked Questions

Is compounded tirzepatide the same as Mounjaro or Zepbound?

Compounded tirzepatide contains the same tirzepatide active ingredient as Mounjaro and Zepbound, but the finished product is prepared by a licensed compounding pharmacy and has not been FDA-approved as a finished drug. Compounded formulations are legal under Section 503A or 503B of the federal compounding statute when prescribed for an individual patient. The PlexusDx Tirzepatide Injection Protocol ($289/mo) and Tirzepatide Oral Protocol ($349/mo) use compounded tirzepatide from licensed U.S. compounding pharmacies.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide — from PlexusDx, MEDVi, Eden, Yucca Health, Willow, TrimRx, or any other provider — is not FDA-approved as a finished product. Mounjaro and Zepbound are the only FDA-approved finished tirzepatide products. Compounded preparations are legal under the federal compounding statute when prescribed by a licensed clinician for an individual patient.

What is the cheapest compounded tirzepatide provider?

On an ongoing month-to-month basis, PlexusDx Tirzepatide Injection at $289/mo carries the lowest ongoing rate in this comparison. TrimRx advertises $349/mo for tirzepatide, but its checkout billed $399/mo month-to-month when we completed signup in July 2026. Yucca Health offers the lowest first-month price ($258 on a 6-month plan), but maintenance pricing rises to $325/mo. That is not a claim to be the cheapest in the category — several programs we have not verified advertise lower figures. Cheapest sticker price is rarely the right decision frame — weigh medication source, clinical oversight, and whether a genetic baseline is included.

Is the PlexusDx Tirzepatide Oral Protocol the same as a tirzepatide tablet?

Yes — the Tirzepatide Oral Protocol is a daily oral compounded tirzepatide formulation, prepared by a licensed U.S. compounding pharmacy and dosed across seven levels from 5mg to 25mg daily. It runs $349/mo month-to-month, or $279/mo on the 6-month plan. MEDVi’s ongoing tirzepatide rate is $399 per month. MEDVi prices its tablet after its intake questionnaire.

Can I switch from injection to oral tirzepatide on PlexusDx?

Yes, with your provider’s guidance. The active ingredient is tirzepatide in both delivery formats, so the clinician can manage the transition between the Tirzepatide Injection Protocol and the Tirzepatide Oral Protocol. Dose equivalencies differ between weekly injection and daily oral dosing — that’s a clinical conversation, not a self-titration decision.

Do PlexusDx protocols include a genetic test?

The Precision Peptide Genetic Test is optional — $298. It maps 49 genes and 58 variants across 14 health pathways, including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GIP/GLP-1 response. None of the other programs compared here includes a DNA-based test. The test does not predict your response or select a medication — your provider makes every prescribing decision.

What are the red flags of a fake or unsafe compounded tirzepatide provider?

Watch for: no prescription required; refusal to name the compounding pharmacy; marketing the product as “generic Mounjaro” or “FDA-approved” (compounded tirzepatide is neither); unusually low prices with no explanation; no clinician involvement; “research use only” labeling; and no third-party reviews on Trustpilot, ConsumerAffairs, or the BBB. Reputable cash-pay programs name their pharmacies, require a licensed clinician’s prescription, and post clear refund and shipping policies.

Related reading on PlexusDx

Related reading on PlexusDx: Tirzepatide Costs, Compounded Tirzepatide vs Zepbound, Tirzepatide vs Semaglutide, Cheapest GLP-1.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for MEDVi, Yucca Health, and Willow is based on each provider’s published rates as of April–July 2026; verify current pricing on each provider’s site. Eden and TrimRx figures were verified by completing each provider’s signup and checkout in July 2026. Actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.